Park Ha Biological Technology Co., Ltd.Securities class action alleges market manipulation and fraudulent promotion, leading to stock collapse.

Robbins LLP reminds investors that a securities class action has been filed against Park Ha Biological Technology Co., Ltd. on behalf of purchasers of its securities between December 27, 2024 and July 8, 2025. The lawsuit alleges Park Ha was the subject of a market manipulation and fraudulent promotion scheme involving social-media misinformation and impersonated financial professionals, and that the company failed to adequately disclose associated risks. According to the complaint, Park Ha's stock price surged from its $4.00 IPO price to an all-time high of $41.49 on July 7, 2025, before collapsing 93% in a single day on July 8, 2025, wiping out more than $1 billion in market capitalization. Investors who suffered losses during the class period may seek appointment as lead plaintiff by the September 28, 2026 deadline.
Park Ha Biological Technology Co., Ltd.Securities class action alleges market manipulation and fraudulent promotion, leading to stock collapse.